首页> 美国卫生研究院文献>The Cochrane Database of Systematic Reviews >Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease
【2h】

Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease

机译:流感嗜血杆菌口服疫苗可预防慢性支气管炎和慢性阻塞性肺疾病的急性加重

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundChronic bronchitis and chronic obstructive pulmonary disease (COPD) are serious conditions in which patients are predisposed to viral and bacterial infections resulting in potentially fatal acute exacerbations. Chronic obstructive pulmonary disease is defined as a lung disease characterised by obstruction to lung airflow that interferes with normal breathing. Antibiotic therapy has not been particularly useful in eradicating bacteria such as non‐typeable Haemophilus influenzae (NTHi) because they are naturally occurring flora of the upper respiratory tract in many people. However, they can cause opportunistic infection. An oral NTHi vaccine has been developed to protect against recurrent infective acute exacerbations in chronic bronchitis.
机译:背景慢性支气管炎和慢性阻塞性肺疾病(COPD)是严重的疾病,患者容易感染病毒和细菌,导致潜在的致命急性加重。慢性阻塞性肺疾病定义为以阻塞正常呼吸的肺气流阻塞为特征的肺部疾病。抗生素疗法在消除细菌如非分型流感嗜血杆菌(NTHi)方面并不是特别有用,因为它们是许多人中天然存在的上呼吸道菌群。但是,它们可能导致机会性感染。已经开发了口服NTHi疫苗来预防慢性支气管炎的反复感染性急性加重。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号